Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 71335-2556

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 71335-2556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure (Chemicalstructure)

FDA Label Image

Label (Lbl713352556)

Label (Lbl713352556)
Each film-coated extended-release tablet contains 500 mg of Ranolazine. The usual dosage can be found by scanning the QR code on the package insert. These tablets should be stored at 20°C to 25°C and should not be crushed or chewed. The package is child-resistant, and the tablets should be kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.